Table 5.

Correlation between the amplification and molecular breast subtypes.

Region of amplification	Basal	Non Basal	p-value	ERBB2	Non ERBB2	p-value	Luminal A	Non Luminal A	p-value
	No. of patients (%)			No. of patients (%)			No. of patients (%)
11q13
Amplification	1 (5.5)	22 (45.8)	p = 0.006	2 (25)	21 (36.2)	NS	19 (57.6)	4 (12.1)	p = 0.0003
No Amplification	17 (94.5)	26 (54.2)		6 (75)	37 (63.8)		14 (42.4)	29 (87.9)
12p13
Amplification	5 (27.8)	2 (4.2)	p = 0.02	1 (11.1)	6 (10.5)	NS	1 (3.1)	6 (17.6)	NS
No Amplification	13 (72.2)	46 (95.8)		8 (88.9)	51 (89.5)		31 (96.9)	28 (82.4)
17q12
Amplification	0 (0)	6 (17.6)	NS	5 (71.4)	1 (2.2)	p = 2.061e-06	0 (0)	6 (20)	NS
No Amplification	19 (100)	28 (82.4)		2 (28.6)	45 (97.8)		23 (100)	24 (80)	p = 0.065

NS: Not significant